心臓ポンプ装置の市場規模、シェア、成長分析：製品別、タイプ別、セラピー別、地域別 - 産業予測 2025～2032年

心臓ポンプ装置市場規模は2023年に31億米ドルと評価され、2024年の37億8,000万米ドルから2032年には185億6,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは22.0％で成長する見通しです。

世界の心臓ポンプ装置市場は、心血管疾患の有病率の上昇と心不全の発生率の増加により、堅調な成長を遂げています。メーカー各社は、当社の包括的なバリューチェーン分析を活用することで、イノベーションを通じて競争優位性を高めることができます。高齢化社会は、重篤な心疾患の患者をサポートするために不可欠なこれらの重要なデバイスの需要をさらに促進しています。小型化や機能性の向上などの技術的進歩は、患者の転帰と採用率を大幅に押し上げています。特に、磁気浮上式補助人工心臓（VAD）の出現は、合併症の少ない優れた心臓サポートを提供し、状況を一変させました。さらに、移植不適格患者の恒久的な解決策としての機械的循環補助へのシフトは、特に持続的なCAGR成長が見込まれる米国において、市場機会を拡大しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ分析

心臓ポンプ装置市場規模：製品別& CAGR（2025-2032）

• 市場概要
• 補助人工心臓
  • 左心室補助装置
  • 経皮的心室補助装置
  • 両心室補助装置
  • 右心室補助装置
• 大動脈内バルーンポンプ
• 人工心臓総数

心臓ポンプ装置市場規模：タイプ別& CAGR（2025-2032）

• 市場概要
• 埋め込み型心臓ポンプ装置
• 体外心臓ポンプ装置

心臓ポンプ装置市場規模：セラピー別& CAGR（2025-2032）

• 市場概要
• 植込型補助人工心臓（BTT）
• 移植登録となるまでの橋渡し（BTC）
• デスティネーションセラピー（DT）
• その他の治療法

心臓ポンプ装置市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Abbott Laboratories（US）
• Medtronic PLC（Ireland）
• LivaNova PLC（United Kingdom）
• Berlin Heart GmbH（Germany）
• Getinge AB（Sweden）
• Terumo Corporation（Japan）
• Teleflex Incorporated（US）
• Jarvik Heart, Inc.（US）
• Fresenius Medical Care AG & Co. KGaA（Germany）
• Calon Cardio（United Kingdom）
• BiVACOR Inc.（Australia）
• Leviticus Cardio Ltd.（Israel）
• CARMAT SA（France）
• FineHeart SA（France）
• MyLVAD（US）
• MicroPort Scientific Corporation（China）
• TandemLife, a LivaNova company（US）

結論と提言

Heart Pump Device Market size was valued at USD 3.1 billion in 2023 and is poised to grow from USD 3.78 billion in 2024 to USD 18.56 billion by 2032, growing at a CAGR of 22.0% during the forecast period (2025-2032).

The global heart pump device market is witnessing robust growth, driven by the rising prevalence of cardiovascular diseases and the increasing incidence of heart failure. As manufacturers leverage our comprehensive value chain analysis, they can enhance their competitive advantage through innovation. The aging population is further fueling demand for these critical devices, essential for supporting patients with severe cardiac conditions. Technological advancements, such as miniaturization and improved functionality, have significantly boosted patient outcomes and adoption rates. Notably, the emergence of magnetically levitated ventricular assist devices (VADs) has transformed the landscape, offering superior heart support with fewer complications. Additionally, the shift towards mechanical circulatory support as a permanent solution for patients ineligible for transplant is expanding market opportunities, particularly in the U.S., where sustainable CAGR growth is anticipated.

Top-down and bottom-up approaches were used to estimate and validate the size of the Heart Pump Device market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Heart Pump Device Market Segments Analysis

Global Heart Pump Device Market is segmented by Product, Type, Therapy and region. Based on Product, the market is segmented into Ventricular Assist Devices, Intra-Aortic Balloon Pumps and Total Artificial Hearts. Based on Type, the market is segmented into Implantable Heart Pump Devices and Extracorporeal Heart Pump Devices. Based on Therapy, the market is segmented into Bridge-To-Transplant (BTT), Bridge-To-Candidacy (BTC), Destination Therapy (DT) and Other Therapies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Heart Pump Device Market

Continuous innovation in heart pump technology has tremendously enhanced the performance and efficacy of these devices, driving the Heart Pump Device market. Recent advancements have produced smaller, more resilient, and efficient heart pumps, significantly boosting patient comfort and overall quality of life. A notable example is the emergence of magnetically levitated ventricular assist devices (LVADs), which have minimized device-related complications while yielding better patient outcomes. This ongoing development not only addresses the immediate needs of patients with heart failure but also underscores the commitment of manufacturers to improve heart pump solutions, ultimately expanding market potential and fostering growth in the healthcare industry.

Restraints in the Heart Pump Device Market

The heart pump device market faces notable constraints primarily due to the intricate and advanced nature of these medical technologies, which results in high manufacturing and acquisition costs. This substantial financial burden impacts patients, healthcare providers, and healthcare systems, limiting access to these essential devices. Additionally, inadequate reimbursement coverage for heart pump devices in certain areas further complicates the situation, making it challenging for patients to obtain these critical technologies. As a result, the combination of prohibitive costs and limited financial support inhibits the widespread adoption and utilization of heart pump devices, ultimately affecting patient care and outcomes.

Market Trends of the Heart Pump Device Market

The Heart Pump Device market is witnessing a notable trend towards the integration of compatible devices that enhance pump performance and patient outcomes. This includes advanced control units that optimize pump flow management and tailored power sources providing extended battery life, ensuring uninterrupted operation. Furthermore, the incorporation of sophisticated monitoring and data management features facilitates real-time remote patient tracking, significantly improving care coordination. As healthcare providers increasingly prioritize personalized, efficient solutions, the surge in demand for these compatible technologies is transforming the landscape of cardiovascular care, driving innovation and growth within the heart pump device sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Study Analysis

Global Heart Pump Device Market Size by Product & CAGR (2025-2032)

• Market Overview
• Ventricular Assist Devices
  • Left Ventricular Assist Devices
  • Percutaneous Ventricular Assist Devices
  • Biventricular Assist Devices
  • Right Ventricular Assist Devices
• Intra-Aortic Balloon Pumps
• Total Artificial Hearts

Global Heart Pump Device Market Size by Type & CAGR (2025-2032)

• Market Overview
• Implantable Heart Pump Devices
• Extracorporeal Heart Pump Devices

Global Heart Pump Device Market Size by Therapy & CAGR (2025-2032)

• Market Overview
• Bridge-To-Transplant (BTT)
• Bridge-To-Candidacy (BTC)
• Destination Therapy (DT)
• Other Therapies

Global Heart Pump Device Market Size & CAGR (2025-2032)

• North America (Product, Type, Therapy)
  • US
  • Canada
• Europe (Product, Type, Therapy)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Type, Therapy)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Type, Therapy)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Type, Therapy)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic PLC (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Berlin Heart GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jarvik Heart, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Medical Care AG & Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Calon Cardio (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BiVACOR Inc. (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Leviticus Cardio Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CARMAT SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FineHeart SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MyLVAD (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TandemLife, a LivaNova company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations